share_log

HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $30 Price Target

HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $30 Price Target

HC Wainwright & Co. 重申買入Olema Pharmaceuticals,維持30美元的目標價格
Benzinga ·  2024/12/11 03:27  · 評級/大行評級

HC Wainwright & Co. analyst Emily Bodnar reiterates Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and maintains $30 price target.

HC Wainwright & Co. 分析師Emily Bodnar重申對Olema Pharmaceuticals (納斯達克:OLMA)的買入評級,並維持30美元的價格目標。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論